Works matching IS 1470269X AND DT 2006 AND VI 6 AND IP 3

Results: 11

Use of genomic signatures in therapeutics development in oncology and other diseases.
Published in:
Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 166, doi. 10.1038/sj.tpj.6500349
By:
- Simon, R.;
- Wang, S.-J.
Publication type:
Article
Influence of phenotype and pharmacokinetics on β-blocker drug target pharmacogenetics.
Published in:
Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 174, doi. 10.1038/sj.tpj.6500354
By:
- Beitelshees, A. L.;
- Zineh, I.;
- Yarandi, H. N.;
- Pauly, D. F.;
- Johnson, J. A.
Publication type:
Article
Linkage disequilibrium and association with methamphetamine dependence/psychosis of μ-opioid receptor gene polymorphisms.
Published in:
Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 179, doi. 10.1038/sj.tpj.6500355
By:
- Ide, S.;
- Kobayashi, H.;
- Ujike, H.;
- Ozaki, N.;
- Sekine, Y.;
- Inada, T.;
- Harano, M.;
- Komiyama, T.;
- Yamada, M.;
- Iyo, M.;
- Iwata, N.;
- Tanaka, K.;
- Shen, H.;
- Iwahashi, K.;
- Itokawa, M.;
- Minami, M.;
- Satoh, M.;
- Ikeda, K.;
- Sora, I.
Publication type:
Article
Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence.
Published in:
Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 194, doi. 10.1038/sj.tpj.6500358
By:
- Dahl, J. P.;
- Jepson, C.;
- Levenson, R.;
- Wileyto, E. P.;
- Patterson, F.;
- Berrettini, W. H.;
- Lerman, C.
Publication type:
Article
The role of Gilbert's syndrome and frequent NAT2 slow acetylation polymorphisms in the pharmacokinetics of retigabine.
Published in:
Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 211, doi. 10.1038/sj.tpj.6500359
By:
- Hermann, R.;
- Borlak, J.;
- Munzel, U.;
- Niebch, G.;
- Fuhr, U.;
- Maus, J.;
- Erb, K.
Publication type:
Article
Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine.
Published in:
Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 162, doi. 10.1038/sj.tpj.6500361
By:
- Kalow, W.
Publication type:
Article
Relevance of frequent μ-opioid receptor polymorphisms for opioid activity in healthy volunteers.
Published in:
Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 200, doi. 10.1038/sj.tpj.6500362
By:
- Lötsch, J.;
- Geisslinger, G.
Publication type:
Article
Pharmacogenomics and regulatory decision making: an international perspective.
Published in:
Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 154, doi. 10.1038/sj.tpj.6500364
By:
- Mendrick, D. L.;
- Brazell, C.;
- Mansfield, E. A.;
- Pietrusko, R.;
- Barilero, I.;
- Hackett, J.;
- Stürzebecher, S.;
- Jacobson-Kram, D.
Publication type:
Article
Estrogen-metabolizing gene polymorphisms in the assessment of female hormone-dependent cancer risk.
Published in:
Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 189, doi. 10.1038/sj.tpj.6500365
By:
- Mikhailova, O. N.;
- Gulyaeva, L. F.;
- Prudnikov, A. V.;
- Gerasimov, A. V.;
- Krasilnikov, S. E.
Publication type:
Article
Pharmacovigilance in a genomic era.
Published in:
Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 158, doi. 10.1038/sj.tpj.6500370
By:
- Farahani, P.;
- Levine, M.
Publication type:
Article
In This Issue.
Published in:
Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 153, doi. 10.1038/sj.tpj.6500399
Publication type:
Article